![Kenneth O'Brien](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth O'Brien
Corporate Officer/Principal presso NinePoint Medical, Inc.
Profilo
Kenneth O'Brien is currently a Senior Director-Software Development at NinePoint Medical, Inc. He previously worked as a Director-Software Engineering at Infraredx, Inc. and as a Staff Engineer at Applied Biosystems, Inc. Mr. O'Brien received his undergraduate degree from Boston University and his graduate degree from Rensselaer Polytechnic Institute.
Posizioni attive di Kenneth O'Brien
Società | Posizione | Inizio |
---|---|---|
NinePoint Medical, Inc.
![]() NinePoint Medical, Inc. Medical SpecialtiesHealth Technology NinePoint Medical, Inc. develops and manufactures medical devices. It designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, evaluation of human tissue microstructure. The company is headquartered in Bedford, MA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Kenneth O'Brien
Società | Posizione | Fine |
---|---|---|
Applied Biosystems, Inc.
![]() Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Corporate Officer/Principal | - |
Infraredx, Inc.
![]() Infraredx, Inc. Medical SpecialtiesHealth Technology Infraredx, Inc. is a developed cardiovascular imaging devices. Its product were TVC Imaging System dual-modality intravascular imaging system with the ability to assess vessel structure and plaque composition via integrated NIRS near infrared spectroscopy lipid-core plaque LCP detection and enhanced IVUS imaging technology. The company was founded by James E. Muller in 1999 and is headquartered in Bedford, MA. | Corporate Officer/Principal | - |
Formazione di Kenneth O'Brien
Boston University | Undergraduate Degree |
Rensselaer Polytechnic Institute | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
NinePoint Medical, Inc.
![]() NinePoint Medical, Inc. Medical SpecialtiesHealth Technology NinePoint Medical, Inc. develops and manufactures medical devices. It designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, evaluation of human tissue microstructure. The company is headquartered in Bedford, MA. | Health Technology |
Infraredx, Inc.
![]() Infraredx, Inc. Medical SpecialtiesHealth Technology Infraredx, Inc. is a developed cardiovascular imaging devices. Its product were TVC Imaging System dual-modality intravascular imaging system with the ability to assess vessel structure and plaque composition via integrated NIRS near infrared spectroscopy lipid-core plaque LCP detection and enhanced IVUS imaging technology. The company was founded by James E. Muller in 1999 and is headquartered in Bedford, MA. | Health Technology |
Applied Biosystems, Inc.
![]() Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
- Borsa valori
- Insiders
- Kenneth O'Brien